Detalhe da pesquisa
1.
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum.
Ann Surg Oncol;
2024 Apr 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38689169
2.
Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy.
Ann Surg Oncol;
2024 May 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38717544
3.
Finding the Balance Between Reduced Opioid Prescribing and Patient-reported Pain Management Among General Surgery Patients.
Ann Surg;
278(2): 208-215, 2023 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35993582
4.
Oncologic Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Highly Selected Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Ann Surg Oncol;
30(12): 7833-7839, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37596449
5.
Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
Ann Surg Oncol;
30(8): 4840-4851, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37208566
6.
Accuracy of DOTATATE PET imaging in the preoperative planning of small bowel neuroendocrine tumor resection.
J Surg Oncol;
128(7): 1072-1079, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37529970
7.
Circumstances and implications of conversion from minimally invasive to open liver resection: a multi-center analysis from the AMILES registry.
Surg Endosc;
37(12): 9201-9207, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37845532
8.
Laparoscopic versus open liver resections for intrahepatic cholangiocarcinoma and gallbladder cancer: the Mayo clinic experience.
HPB (Oxford);
25(3): 339-346, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36707278
9.
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis.
Oncologist;
27(7): 573-578, 2022 07 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35348774
10.
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors.
Ann Surg Oncol;
29(11): 6949-6957, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35731358
11.
Outcomes of pancreatectomy with portomesenteric venous resection and reconstruction for locally advanced pancreatic neuroendocrine neoplasms.
HPB (Oxford);
24(7): 1186-1193, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35078716
12.
Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors.
J Surg Oncol;
124(7): 1077-1084, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34310723
13.
Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis.
Ann Surg Oncol;
31(6): 3976-3977, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38619707
14.
ASO Visual Abstract: Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum.
Ann Surg Oncol;
2024 May 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38780689
15.
ASO Visual Abstract: Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy.
Ann Surg Oncol;
2024 May 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38809451
16.
Gastroenteropancreatic neuroendocrine tumors in Iceland: a population-based study.
Scand J Gastroenterol;
54(1): 69-75, 2019 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30638086
17.
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm.
Lancet Oncol;
24(5): e189, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37142377
18.
Reply to "Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis".
Ann Surg Oncol;
30(9): 5459-5460, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37394671
19.
ASO Author Reflections: Long-Term Outcomes after Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases.
Ann Surg Oncol;
30(8): 4852-4853, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36940040
20.
ASO Visual Abstract: Oncologic Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Highly Selected Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Ann Surg Oncol;
30(12): 7872-7873, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37610494